See more : Omnicom Group Inc. (0KBK.L) Income Statement Analysis – Financial Results
Complete financial analysis of Mitsui Chemicals, Inc. (MITUF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mitsui Chemicals, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Quizam Media Corporation (QQ.CN) Income Statement Analysis – Financial Results
- Amper, S.A. (AMP.MC) Income Statement Analysis – Financial Results
- Shenzhen Investment Holdings Bay Area Development Company Limited (SHIHF) Income Statement Analysis – Financial Results
- RENK Group AG (R3NK.F) Income Statement Analysis – Financial Results
- Appili Therapeutics Inc. (APLI.TO) Income Statement Analysis – Financial Results
Mitsui Chemicals, Inc. (MITUF)
About Mitsui Chemicals, Inc.
Mitsui Chemicals, Inc. engages in the mobility, health care, food and packaging, basic materials, and other businesses. The company's Mobility segment develops elastomers, performance compounds, functional polymers, polypropylene compounds, and performance polymers; and offers services related to the development of automotive and industrial products. Its Health Care segment offers vision care materials, nonwoven fabrics, dental materials, and personal care materials. The Food & Packaging segment provides coating and engineering materials, performance films and sheets, and agrochemical products. The Basic Materials segment provides ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid, PET, polyurethane materials, and industrial chemical products. The company also offers civil engineering and construction materials; cosmetics; wood adhesives, paper resins, foliar activator, and other chemical products; polyolefin, urethanes, and synthetic resins and resin films; injection molds and presses; phosphoric acid and fertilizers; spunbonded nonwoven fabrics and synthetic fibers; monomers for optical lenses; and fine chemical products and inorganic chemicals. In addition, it is involved in performance analysis, physical property measurements, and safety tests on chemicals; and placements, temporary works, and insurance and travel services, and consignments, as well as the sale of electronics and information materials. The company sells its products in Japan, China, Asia, the Americas, Europe, and internationally. Mitsui Chemicals, Inc. was founded in 1892 and is headquartered in Tokyo, Japan.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,749.74B | 1,879.55B | 1,612.69B | 1,211.73B | 1,338.99B | 1,482.91B | 1,328.53B | 1,212.28B | 1,343.90B | 1,550.08B | 1,566.05B | 1,406.22B | 1,454.02B | 1,391.71B | 1,207.74B | 1,487.62B | 1,786.68B | 1,688.06B | 1,472.44B | 1,227.55B | 1,089.52B | 1,053.18B | 952.68B | 939.78B | 884.25B | 855.94B |
Cost of Revenue | 1,378.95B | 1,498.05B | 1,233.95B | 917.88B | 1,041.84B | 1,166.58B | 1,019.16B | 919.27B | 1,069.45B | 1,308.54B | 1,353.54B | 1,233.30B | 1,261.20B | 1,174.18B | 1,039.52B | 1,341.11B | 1,509.31B | 1,402.02B | 1,217.56B | 968.23B | 861.97B | 823.52B | 730.06B | 720.52B | 659.33B | 632.04B |
Gross Profit | 370.80B | 381.49B | 378.74B | 293.84B | 297.15B | 316.33B | 309.37B | 293.01B | 274.45B | 241.53B | 212.51B | 172.92B | 192.82B | 217.54B | 168.22B | 146.51B | 277.37B | 286.04B | 254.87B | 259.32B | 227.55B | 229.66B | 222.62B | 219.26B | 224.92B | 223.91B |
Gross Profit Ratio | 21.19% | 20.30% | 23.49% | 24.25% | 22.19% | 21.33% | 23.29% | 24.17% | 20.42% | 15.58% | 13.57% | 12.30% | 13.26% | 15.63% | 13.93% | 9.85% | 15.52% | 16.94% | 17.31% | 21.12% | 20.89% | 21.81% | 23.37% | 23.33% | 25.44% | 26.16% |
Research & Development | 0.00 | 43.00B | 38.10B | 33.80B | 36.37B | 35.80B | 33.38B | 30.78B | 31.49B | 32.47B | 33.57B | 32.00B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 282.66B | 284.59B | 239.36B | 211.98B | 226.59B | 130.32B | 120.45B | 113.12B | 122.67B | 115.10B | 101.70B | 85.14B | 0.00 | 0.00 | 0.00 | 0.00 | 200.20B | 194.36B | 196.17B | 178.83B | 173.61B | 173.20B | 180.24B | 164.75B | 169.18B | 165.68B |
Selling & Marketing | 0.00 | 77.34B | 68.64B | 58.16B | 58.48B | 56.79B | 52.04B | 48.34B | 49.36B | 52.00B | 52.52B | 51.69B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 282.66B | 233.51B | 195.59B | 168.25B | 191.85B | 187.11B | 172.50B | 161.46B | 172.03B | 167.10B | 154.23B | 136.83B | 0.00 | 0.00 | 0.00 | 0.00 | 200.20B | 194.36B | 196.17B | 178.83B | 173.61B | 173.20B | 180.24B | 164.75B | 169.18B | 165.68B |
Other Expenses | 14.02B | 0.00 | 0.00 | 0.00 | -4.03B | 585.00M | 1.54B | -405.00M | -1.11B | -491.00M | 3.33B | 7.11B | -34.00M | 1.38B | 1.39B | 5.05B | -1.96B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 296.67B | 263.15B | 235.84B | 216.94B | 228.01B | 210.36B | 214.47B | 205.11B | 230.59B | 203.46B | 219.76B | 170.64B | 171.26B | 176.99B | 177.68B | 192.00B | 200.20B | 194.36B | 196.17B | 178.83B | 173.61B | 173.20B | 180.24B | 164.75B | 169.18B | 165.68B |
Cost & Expenses | 1,675.62B | 1,761.20B | 1,469.79B | 1,134.82B | 1,269.85B | 1,376.94B | 1,233.63B | 1,124.38B | 1,300.04B | 1,512.00B | 1,573.29B | 1,403.94B | 1,432.46B | 1,351.17B | 1,217.20B | 1,533.11B | 1,709.50B | 1,596.38B | 1,413.73B | 1,147.06B | 1,035.58B | 996.72B | 910.30B | 885.27B | 828.51B | 797.72B |
Interest Income | 13.87B | 1.07B | 1.63B | 2.66B | 674.00M | 672.00M | 690.00M | 2.13B | 2.55B | 2.24B | 3.29B | 3.08B | 273.00M | 213.00M | 458.00M | 400.00M | 640.00M | 0.00 | 0.00 | 1.41B | 1.43B | 1.85B | 2.25B | 1.50B | 1.81B | 1.74B |
Interest Expense | 14.66B | 17.40B | 12.21B | 8.13B | 9.15B | 5.53B | 5.48B | 5.75B | 6.62B | 7.35B | 7.37B | 6.78B | 7.06B | 7.62B | 8.48B | 9.32B | 9.51B | 8.10B | 6.04B | 6.35B | 7.42B | 9.11B | 10.81B | 11.77B | 13.37B | 14.77B |
Depreciation & Amortization | 95.25B | 92.08B | 84.22B | 76.62B | 76.01B | 49.50B | 45.65B | 44.06B | 48.64B | 48.25B | 48.14B | 43.86B | 62.75B | 69.24B | 74.88B | 81.37B | 72.60B | 70.21B | 70.10B | 56.77B | 56.10B | 56.85B | 56.61B | 51.76B | 52.63B | 51.08B |
EBITDA | 183.24B | 182.81B | 216.99B | 157.75B | 121.04B | 142.93B | 149.15B | 144.84B | 119.57B | 90.29B | 44.98B | 49.85B | 86.16B | 121.82B | 67.27B | 39.93B | 148.25B | 162.85B | 129.18B | 143.58B | 116.81B | 129.87B | 104.25B | 107.76B | 110.18B | 111.05B |
EBITDA Ratio | 10.47% | 9.73% | 13.45% | 13.02% | 9.04% | 9.64% | 11.23% | 11.95% | 8.90% | 5.82% | 4.66% | 3.42% | 6.37% | 8.31% | 5.81% | 2.68% | 8.30% | 9.70% | 8.77% | 11.70% | 10.72% | 12.33% | 10.94% | 11.47% | 12.46% | 12.97% |
Operating Income | 74.12B | 90.73B | 132.76B | 81.13B | 68.93B | 93.43B | 103.49B | 100.78B | 70.93B | 42.04B | 24.90B | 4.29B | 21.56B | 40.55B | -9.46B | -45.49B | 77.18B | 91.68B | 58.71B | 80.49B | 53.94B | 56.46B | 42.38B | 54.51B | 55.74B | 58.23B |
Operating Income Ratio | 4.24% | 4.83% | 8.23% | 6.70% | 5.15% | 6.30% | 7.79% | 8.31% | 5.28% | 2.71% | 1.59% | 0.31% | 1.48% | 2.91% | -0.78% | -3.06% | 4.32% | 5.43% | 3.99% | 6.56% | 4.95% | 5.36% | 4.45% | 5.80% | 6.30% | 6.80% |
Total Other Income/Expenses | -793.00M | 26.55B | 8.51B | -3.83B | -3.18B | 11.87B | -9.28B | -16.38B | -29.62B | -6.20B | -35.44B | -5.09B | -5.21B | 4.41B | -6.62B | -19.94B | -32.62B | -7.14B | 14.22B | -25.84B | -31.71B | -17.50B | -32.14B | -26.12B | -29.60B | -36.10B |
Income Before Tax | 73.33B | 117.28B | 141.27B | 74.24B | 68.46B | 105.30B | 94.21B | 85.77B | 41.30B | 35.84B | -10.54B | -796.00M | 16.35B | 44.96B | -16.08B | -65.43B | 44.55B | 84.54B | 72.93B | 54.65B | 22.23B | 38.96B | 10.24B | 28.39B | 26.14B | 22.13B |
Income Before Tax Ratio | 4.19% | 6.24% | 8.76% | 6.13% | 5.11% | 7.10% | 7.09% | 7.08% | 3.07% | 2.31% | -0.67% | -0.06% | 1.12% | 3.23% | -1.33% | -4.40% | 2.49% | 5.01% | 4.95% | 4.45% | 2.04% | 3.70% | 1.07% | 3.02% | 2.96% | 2.59% |
Income Tax Expense | 19.56B | 27.14B | 22.72B | 10.02B | 22.17B | 18.77B | 15.19B | 11.92B | 11.84B | 11.48B | 11.37B | 6.83B | 8.79B | 11.05B | 11.65B | 40.62B | 19.43B | 27.42B | 27.68B | 23.05B | 7.92B | 13.47B | 1.83B | 10.52B | 8.18B | 12.67B |
Net Income | 50.00B | 82.94B | 109.99B | 57.87B | 33.97B | 76.12B | 71.59B | 64.84B | 22.96B | 17.26B | -25.14B | -8.15B | -1.01B | 24.85B | -28.01B | -95.24B | 24.83B | 52.30B | 44.13B | 26.19B | 12.47B | 20.32B | 7.65B | 17.07B | 16.04B | 7.74B |
Net Income Ratio | 2.86% | 4.41% | 6.82% | 4.78% | 2.54% | 5.13% | 5.39% | 5.35% | 1.71% | 1.11% | -1.61% | -0.58% | -0.07% | 1.79% | -2.32% | -6.40% | 1.39% | 3.10% | 3.00% | 2.13% | 1.14% | 1.93% | 0.80% | 1.82% | 1.81% | 0.90% |
EPS | 262.99 | 431.17 | 565.45 | 298.00 | 194.94 | 385.60 | 358.38 | 324.05 | 114.74 | 86.21 | -125.51 | -40.68 | -5.03 | 124.00 | -165.18 | -627.31 | 161.08 | 333.40 | 281.00 | 166.30 | 78.90 | 128.60 | 48.50 | 108.15 | 102.85 | 4.99M |
EPS Diluted | 262.99 | 431.17 | 565.45 | 298.00 | 194.94 | 385.60 | 358.38 | 324.05 | 114.74 | 86.21 | -125.51 | -40.68 | -5.03 | 124.00 | -165.18 | -627.31 | 161.08 | 333.40 | 281.00 | 166.30 | 78.90 | 127.35 | 48.50 | 107.20 | 102.05 | 4.99M |
Weighted Avg Shares Out | 190.12M | 192.35M | 194.52M | 194.20M | 194.65M | 197.39M | 199.75M | 200.09M | 200.14M | 200.22M | 200.29M | 200.34M | 200.37M | 200.43M | 169.57M | 151.82M | 154.16M | 156.86M | 157.03M | 157.50M | 158.00M | 158.01M | 157.75M | 157.82M | 155.97M | 1.55K |
Weighted Avg Shares Out (Dil) | 190.12M | 192.35M | 194.52M | 194.20M | 194.65M | 197.39M | 199.75M | 200.09M | 200.14M | 200.22M | 200.29M | 200.34M | 200.37M | 200.43M | 169.57M | 151.82M | 154.16M | 156.86M | 157.03M | 157.50M | 158.00M | 159.56M | 157.75M | 159.22M | 157.20M | 1.55K |
Mitsui Chemicals and ARRK Supply Materials for High-Performance Concept Car
Mitsui Chemicals Singapore R&D Centre: Donation of posica™ kukkiri™ film to Jamiyah Nursing Home
Mitsui Chemicals Group and ARRK Thailand to Organize the First MotionTech 2024 Exhibition
Mitsui Chemicals Develops Diffrar™ Optical Polymer Wafers for AR Glasses
Japan's Mitsui, others to jointly study hydrogen, ammonia supply chain in Osaka
2024 Mitsui Chemicals Catalysis Science Awards
Mitsui Chemicals' MR™ High Refractive Index Ophthalmic Lens Monomers Picked Up by Costco as Standard Option for Glasses
Source: https://incomestatements.info
Category: Stock Reports